{
    "Question_1": {
        "Context": "The journal EJNMMI Radiopharmacy and Chemistry focuses on the development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging.",
        "Question": "What is the Impact Factor of EJNMMI Radiopharmacy and Chemistry for the year 2022?",
        "A": "2.3",
        "B": "4.6",
        "C": "6.8",
        "D": "8.2",
        "Answer": "B",
        "Source": "The Impact Factor 2022 of EJNMMI Radiopharmacy and Chemistry is 4.6."
    },
    "Question_2": {
        "Context": "EJNMMI Radiopharmacy and Chemistry covers the content of new research in the field of radiopharmacy and radiochemistry.",
        "Question": "What is the main focus of EJNMMI Radiopharmacy and Chemistry?",
        "A": "Development of new surgical techniques",
        "B": "Development of new imaging and therapeutic agents for nuclear medicine",
        "C": "Development of new antibiotics",
        "D": "Development of new vaccines",
        "Answer": "B",
        "Source": "The journal provides a platform for chemists, pharmacists, and basic scientists to present their views and scientific work in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging."
    },
    "Question_3": {
        "Context": "The journal EJNMMI Radiopharmacy and Chemistry is interested in various topics related to radiopharmacy and radiochemistry.",
        "Question": "Which of the following is an area of interest for EJNMMI Radiopharmacy and Chemistry based on recent developments?",
        "A": "Astronomy",
        "B": "Botany",
        "C": "Artificial Intelligence in Radiopharmaceutical field",
        "D": "Zoology",
        "Answer": "C",
        "Source": "Artificial Intelligence is emerging and found its application in the Radiopharmaceutical field."
    },
    "Question_4": {
        "Context": "EJNMMI Radiopharmacy and Chemistry aims to support the field by implementing novel methodologies.",
        "Question": "What is the purpose of the collection open for submission dedicated to Best Practices?",
        "A": "To promote outdated methodologies",
        "B": "To hinder the implementation of novel methodologies",
        "C": "To support the field in implementing novel methodologies",
        "D": "To discourage the use of best practices",
        "Answer": "C",
        "Source": "A collection is open for submission dedicated only to Best Practices in order to support the field in implementing novel methodologies."
    },
    "Question_5": {
        "Context": "The Editorial Board of EJNMMI Radiopharmacy and Chemistry consists of scientists in the field.",
        "Question": "How many scientists are currently part of the Editorial Board?",
        "A": "50",
        "B": "80",
        "C": "100",
        "D": "120",
        "Answer": "B",
        "Source": "The Editorial Board consists now of 80 scientists in the field and is continuously expanding."
    },
    "Question_6": {
        "Context": "EJNMMI Radiopharmacy and Chemistry is interested in providing insight into novel concepts.",
        "Question": "What type of concepts does the journal aim to provide insight into?",
        "A": "Traditional concepts",
        "B": "Novel concepts",
        "C": "Outdated concepts",
        "D": "Controversial concepts",
        "Answer": "B",
        "Source": "The journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community."
    },
    "Question_7": {
        "Context": "The journal EJNMMI Radiopharmacy and Chemistry is now interested in additional topics.",
        "Question": "What is one of the new areas of interest for the journal?",
        "A": "Cooking recipes",
        "B": "Production methods for radionuclides",
        "C": "Fashion trends",
        "D": "Sports news",
        "Answer": "B",
        "Source": "The journal is now also interested in production methods for radionuclides."
    },
    "Question_8": {
        "Context": "EJNMMI Radiopharmacy and Chemistry aims to establish its role as a platform for communication.",
        "Question": "What is the journal aiming to achieve in terms of its role?",
        "A": "To limit communication",
        "B": "To establish a platform for communication",
        "C": "To discourage publications",
        "D": "To avoid submissions",
        "Answer": "B",
        "Source": "I hope to continue all the good work and aim that EJNMMI Radiopharmacy and Chemistry can further increase and establish its role being a strong platform for communication and publications in the field of Radiopharmacy and Radiochemistry."
    },
    "Question_9": {
        "Context": "EJNMMI Radiopharmacy and Chemistry encourages submissions from authors.",
        "Question": "What is the Editor-in-Chief looking forward to receiving?",
        "A": "Complaints",
        "B": "Subscriptions",
        "C": "Submissions",
        "D": "Queries",
        "Answer": "C",
        "Source": "I am very much looking forward to receive your submissions to EJNMMI Radiopharmacy and Chemistry."
    },
    "Question_10": {
        "Context": "The journal EJNMMI Radiopharmacy and Chemistry provides online submission guidelines.",
        "Question": "Where can additional metrics like downloads and turnaround times be found?",
        "A": "In a physical book",
        "B": "On the moon",
        "C": "On the journal website",
        "D": "In a newspaper",
        "Answer": "C",
        "Source": "The online submission and the submission guidelines for the considered article types are available on the journal website."
    }
}